Your immune system already has cancer killers built in.

They're called Natural Killer cells. Unlike T cells, they don't need to be trained, matched to a patient, or given permission. They see a cancer cell. They destroy it.
The problem has always been scale.
That's changing.
Yale scientists just engineered NK cells to express a single gene, OR7A10, and watched them eradicate breast, colon, and ovarian tumors in mice. The bigger breakthrough isn't the gene. It's the manufacturing model.
One donor. Millions of doses. No patient match required.
CAR-T, the current gold standard, takes weeks to make, costs hundreds of thousands, and requires the patient's own cells. NK cells cross donor barriers without triggering graft-versus-host disease. They're built for off-the-shelf use.
ImmunityBio is already in Phase 2. No chemo. No custom engineering. Outpatient.
We spent decades trying to teach the immune system to fight cancer.
NK cells never needed the lesson.